TABLE OF CONTENTS

1. INTRODUCTION 24
1.1. OBJECTIVES OF THE STUDY 24
1.2. MARKET DEFINITION 24
1.3. OVERVIEW OF ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY MARKET 24
1.4. CURRENCY AND PRICING 25
1.5. LIMITATION 25
1.6. MARKETS COVERED 26
2. MARKET SEGMENTATION 28
2.1. MARKETS COVERED 28
2.2. GEOGRAPHIC SCOPE 29
2.3. YEARS CONSIDERED FOR THE STUDY 30
2.4. CURRENCY AND PRICING 30
2.5. RESEARCH METHODOLOGY 31
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7. SECONDARY SOURCES 35
2.8. ASSUMPTIONS 35
3. MARKET OVERVIEW 36
3.1. DRIVERS 38
?
3.2. RESTRAINTS 40
3.3. OPPORTUNITIES 41
3.4. CHALLENGES 42
4. EXECUTIVE SUMMARY 43
5. PREMIUM INSIGHTS 46
6. ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY MARKET, BY PRODUCT TYPE 49
6.1. OVERVIEW 59
6.2. ORAL APPLIANCES/MOUTHPIECES 61
6.2.1. MANDIBULAR ADVANCEMENT DEVICES (MADS) 63
6.2.1.1. NON-CUSTOM MADS 63
6.2.1.2. CUSTOM-MADE MADS 63
6.2.2. TONGUE-RETAINING DEVICES (TRDS) 63
6.3. NASAL DEVICES 64
6.3.1. EXTERNAL NASAL DILATORS 65
6.3.2. OTHER NASAL DEVICES 65
6.3.2.1. NASAL STENTS 66
6.3.2.2. NASAL CLIPS 66
6.3.2.3. SEPTAL STIMULATORS 67
6.3.2.4. NASAL CONES 67
6.3.2.5. OTHERS 67
6.4. POSITION CONTROL DEVICES 68
6.5. CHIN STRAPS 69
6.6. EPAP THERAPY DEVICES 70
6.7. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES 71
?
7. ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY END-USER 72
7.1. OVERVIEW 73
7.2. HOSPITALS 75
7.3. COMMUNITY HEALTHCARE 76
7.4. SLEEP CLINICS 77
7.5. HOME HEALTHCARE 78
7.6. OTHERS 79
8. ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY TYPE 80
8.1. OVERVIEW 81
8.2. UVULOPALATOPHARYNGOPLASTY (UPPP) 82
8.3. LASER-ASSISTED UVULOPALATOPLASTY (LAUP) 83
8.4. RADIO FREQUENCY ABLATION (SOMNOPLASTY) 84
8.5. PILLAR PROCEDURE 85
8.6. PALATAL STIFFENING PROCEDURES 86
8.7. INJECTION SNOREPLASTY/SCLEROTHERAPY 87
8.8. OTHER ANTI-SNORING SURGICAL PROCEDURES 88
9. ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY DISTRIBUTION CHANNEL 89
9.1. OVERVIEW 90
9.2. RETAIL 92
9.3. DIRECT SALES 93
10. ASIA-PACIFIC ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY GEOGRAPHY 101
10.1. OVERVIEW 102
10.2. ASIA-PACIFIC 1210
10.2.1. CHINA 1510
10.2.2. JAPAN 161
10.2.3. INDIA 164
10.2.4. SOUTH KOREA 167
10.2.5. AUSTRALIA 170
10.2.6. SINGAPORE 173
10.2.7. THAILAND 176
10.2.8. MALAYSIA 179
10.2.9. INDONESIA 1102
10.2.10. PHILIPPINES 1105
10.2.11. REST OF ASIA-PACIFIC 11010
10. COMPANY LANDSCAPE 221
10.1. COMPANY SHARE ANALYSIS; ASIA-PACIFIC 223
11. COMPANY PROFILE. 226
11.1. SLEEPING WELL, LLC 293
11.1.1. COMPANY OVERVIEW 293
11.1.2. COMPANY SNAPSHOT 293
11.1.3. PRODUCT PORTFOLIO 293
11.1.4. RECENT DEVELOPMENTS 294
11.2. APNEA SCIENCES CORPORATION 294
11.2.1. COMPANY OVERVIEW 294
11.2.2. COMPANY SNAPSHOT 294
11.2.3. PRODUCT PORTFOLIO 294
11.2.4. RECENT DEVELOPMENTS 295
11.3. THE PURE SLEEP COMPANY 296
11.3.1. COMPANY OVERVIEW 296
11.3.2. COMPANY SNAPSHOT 296
11.3.3. PRODUCT PORTFOLIO 296
11.3.4. RECENT DEVELOPMENTS 296
11.4. KONINKLIJKE PHILIPS N.V. 297
11.4.1. COMPANY OVERVIEW 297
11.4.2. REVENUE ANALYSIS 297
11.4.3. PRODUCT PORTFOLIO 298
11.4.4. RECENT DEVELOPMENTS 299
11.5. SOMNOMED 300
11.5.1. COMPANY OVERVIEW 300
11.5.2. REVENUE ANALYSIS 300
11.5.3. PRODUCT PORTFOLIO 301
11.5.4. RECENT DEVELOPMENTS 301
11.6. FISHER AND PAYKEL HEALTHCARE LIMITED. 302
11.6.1. COMPANY OVERVIEW 302
11.6.2. REVENUE ANALYSIS 302
11.6.3. PRODUCT PORTFOLIO 303
11.6.4. RECENT DEVELOPMENTS 304
11.7. RESMED 305
11.7.1. COMPANY OVERVIEW 305
11.7.2. REVENUE ANALYSIS 305
11.7.3. PRODUCT PORTFOLIO 306
11.7.4. RECENT DEVELOPMENTS 307
11.8. AIRWAY MANAGEMENT INC. 308
11.8.1. COMPANY OVERVIEW 308
11.8.2. COMPANY SNAPSHOT 308
11.8.3. PRODUCT PORTFOLIO 308
11.8.4. RECENT DEVELOPMENTS 308
11.9. THERAVENT, INC. 309
11.9.1. COMPANY OVERVIEW 309
11.9.2. COMPANY SNAPSHOT 309
11.9.3. PRODUCT PORTFOLIO 309
11.9.4. RECENT DEVELOPMENTS 309
11.10. TOMED GMBH 310
11.10.1. COMPANY OVERVIEW 310
11.10.2. REVENUE ANALYSIS 310
11.10.3. PRODUCT PORTFOLIO 310
11.10.4. RECENT DEVELOPMENTS 310
11.11. GLAXOSMITHKLINE PLC. 311
11.11.1. COMPANY OVERVIEW 311
11.11.2. REVENUE ANALYSIS 311
11.11.3. PRODUCT PORTFOLIO 311
11.11.4. RECENT DEVELOPMENTS 311
11.12. GE HEALTHCARE 313
11.12.1. COMPANY OVERVIEW 313
11.12.2. REVENUE ANALYSIS 313
11.12.3. PRODUCT PORTFOLIO 314
11.12.4. RECENT DEVELOPMENTS 314
11.13. MEDITAS 315
11.13.1. COMPANY OVERVIEW 315
11.13.2. COMPANY SNAPSHOT 315
11.13.3. PRODUCT PORTFOLIO 315
11.13.4. RECENT DEVELOPMENTS 315
11.14. MEDTRONIC 317
11.14.1. COMPANY OVERVIEW 317
11.14.2. REVENUE ANALYSIS 317
11.14.3. PRODUCT PORTFOLIO 318
11.14.4. RECENT DEVELOPMENTS 318
11.15. ACCUMED CORP. 319
11.15.1. COMPANY OVERVIEW 319
11.15.2. COMPANY SNAPSHOT 319
11.15.3. PRODUCT PORTFOLIO 319
11.15.4. RECENT DEVELOPMENTS 319
11.16. IMTHERA MEDICAL 320
11.16.1. COMPANY OVERVIEW 320
11.16.2. COMPANY SNAPSHOT 320
11.16.3. PRODUCT PORTFOLIO 320
11.16.4. RECENT DEVELOPMENTS 320
12. RELATED REPORTS 248